期刊
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA
卷 39, 期 3, 页码 567-+出版社
W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.rdc.2013.02.001
关键词
Osteoarthritis; Imaging; Radiography; MR imaging; Ultrasonography; CT; PET
类别
资金
- Genzyme
- Stryker
- Merck Serono
- Novartis
- Astra Zeneca
- General Electric Healthcare
- National Institutes of Health
Slowing of radiographic joint space narrowing represents the only recommended imaging-based outcome measure to assess structural disease progression in osteoarthritis (OA) clinical trials. There are no effective disease-modifying OA drugs. The ability of magnetic resonance (MR) to image structures within the knee and to visualize cartilage morphology and composition gives MR imaging a critical role in understanding the natural history of the disease and in the search for therapies. In this article, the roles and limitations of conventional radiography and MR imaging, focusing on knee OA, and the use of other modalities in clinical practice and OA research are described.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据